RESUMEN

Potential aerosols containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral particles can be generated during dental treatment. Hence, patient triage is essential to prevent the spread of SARS-CoV-2 in dental clinical settings. The present study described the use of rapid antigen tests for SARS-CoV-2 screening prior to dental treatment in an academic dental clinical setting in Thailand during the pandemic. The opinions of dental personnel toward the use of rapid antigen test screening prior to dental treatment were also assessed. From August 25 to October 3, 2021, dental patients who were expected to receive aerosols generating dental procedures were requested to screen for SARS-CoV-2 using a rapid antigen test before their treatment. A total of 7,618 cases completed the screening process. The average was 212 cases per day. Only five patients (0.07%) were positive for SARS-CoV-2 in the rapid antigen screening tests. All positive cases exhibited mild symptoms. For the questionnaire study, experienced dental personnel frequently and consistently agreed with the use of the rapid antigen test for SARS-CoV-2 screening, which made them feel safer during their patient treatment. However, implementing rapid antigen tests for SARS-CoV-2 may increase the total time spent on a dental appointment. In conclusion, a rapid antigen test could detect the infected individual prior to dental treatment. However, the specificity of rapid antigen tests for SARS-CoV-2 must be taken into account for consideration as a screening process before dental treatment. The enhanced infection control protocols in dental treatment must be consistently implemented.

RESUMEN

The Cox proportional hazards model has been widely used in cancer genomic research that aims to identify genes from high-dimensional gene expression space associated with the survival time of patients. With the increase in expertly curated biological pathways, it is challenging to incorporate such complex networks in fitting a high-dimensional Cox model. This paper considers a Bayesian framework that employs the Ising prior to capturing relations among genes represented by graphs. A spike-and-slab prior is also assigned to each of the coefficients for the purpose of variable selection. The iterated conditional modes/medians (ICM/M) algorithm is proposed for the implementation for Cox models. The ICM/M estimates hyperparameters using conditional modes and obtains coefficients through conditional medians. This procedure produces some coefficients that are exactly zero, making the model more interpretable. Comparisons of the ICM/M and other regularized Cox models were carried out with both simulated and real data. Compared to lasso, adaptive lasso, elastic net, and DegreeCox, the ICM/M yielded more parsimonious models with consistent variable selection. The ICM/M model also provided a smaller number of false positives than the other methods and showed promising results in terms of predictive accuracy. In terms of computing times among the network-aware methods, the ICM/M algorithm is substantially faster than DegreeCox even when incorporating a large complex network. The implementation of the ICM/M algorithm for Cox regression model is provided in R package icmm, available on the Comprehensive R Archive Network (CRAN).

Asunto(s)

RESUMEN

Logistic regression is an effective tool in case-control analysis. With the advanced high throughput technology, a quest to seek a fast and efficient method in fitting high-dimensional logistic regression has gained much interest. An empirical Bayes model for logistic regression is considered in this article. A spike-and-slab prior is used for variable selection purpose, which plays a vital role in building an effective predictive model while making model interpretable. To increase the power of variable selection, we incorporate biological knowledge through the Ising prior. The development of the iterated conditional modes/medians (ICM/M) algorithm is proposed to fit the logistic model that has computational advantage over Markov Chain Monte Carlo (MCMC) algorithms. The implementation of the ICM/M algorithm for both linear and logistic models can be found in R package icmm that is freely available on Comprehensive R Archive Network (CRAN). Simulation studies were carried out to assess the performances of our method, with lasso and adaptive lasso as benchmark. Overall, the simulation studies show that the ICM/M outperform the others in terms of number of false positives and have competitive predictive ability. An application to a real data set from Parkinson's disease study was also carried out for illustration. To identify important variables, our approach provides flexibility to select variables based on local posterior probabilities while controlling false discovery rate at a desired level rather than relying only on regression coefficients.

Asunto(s)

RESUMEN

Recent advances in high-throughput genotyping have motivated genomic selection using high-density markers. However, an increasingly large number of markers brings up both statistical and computational issues and makes it difficult to estimate the breeding values. We propose to apply the penalized orthogonal-components regression (POCRE) method to estimate breeding values. As a supervised dimension reduction method, POCRE sequentially constructs linear combinations of markers, i.e. orthogonal components, such that these components are most closely correlated to the phenotype. Such a dimension reduction is able to group highly correlated predictors and allows for collinear or nearly collinear markers. Different from BayesB, which predetermines hyperparameters, POCRE uses an empirical Bayes thresholding method to obtain data-driven optimal hyperparameters and effectively select important markers when constructing each component. Demonstrated through simulation studies, POCRE greatly reduces the computing time compared with BayesB. On the other hand, unlike fBayesB which slightly sacrifices prediction accuracy for fast computation, POCRE provides similar or even better accuracy of predicting breeding values than BayesB in both simulation studies and real data analyses.

Asunto(s)

RESUMEN

Altered branching and aberrant expression of N-linked glycans is known to be associated with disease states such as cancer. However, the complexity of determining such variations hinders the development of specific glycomic approaches for assessing disease states. Here, we examine a combination of ion mobility spectrometry (IMS) and mass spectrometry (MS) measurements, with principal component analysis (PCA) for characterizing serum N-linked glycans from 81 individuals: 28 with cirrhosis of the liver, 25 with liver cancer, and 28 apparently healthy. Supervised PCA of combined ion-mobility profiles for several, to as many as 10 different mass-to-charge ratios for glycan ions, improves the delineation of diseased states. This extends an earlier study [J. Proteome Res.2008, 7, 1109-1117] of isomers associated with a single glycan (S(1)H(5)N(4)) in which PCA analysis of the IMS profiles appeared to differentiate the liver cancer group from the other samples. Although performed on a limited number of test subjects, the combination of IMS-MS for different combinations of ions and multivariate PCA analysis shows promise for characterizing disease states.

Asunto(s)

RESUMEN

Genome-wide association studies have successfully identified numerous loci at which common variants influence disease risks or quantitative traits of interest. Despite these successes, the variants identified by these studies have generally explained only a small fraction of the variations in the phenotype. One explanation may be that many rare variants that are not included in the common genotyping platforms may contribute substantially to the genetic variations of the diseases. Next-generation sequencing, which would better allow for the analysis of rare variants, is now becoming available and affordable; however, the presence of a large number of rare variants challenges the statistical endeavor to stably identify these disease-causing genetic variants. We conduct a genome-wide association study of Genetic Analysis Workshop 17 case-control data produced by the next-generation sequencing technique and propose that collapsing rare variants within each genetic region through a supervised dimension reduction algorithm leads to several macrovariants constructed for rare variants within each genetic region. A simultaneous association of the phenotype to all common variants and macrovariants is undertaken using a linear discriminant analysis using the penalized orthogonal-components regression algorithm. The results suggest that the proposed analysis strategy shows promise but needs further development.

RESUMEN

Next-generation sequencing technologies enable us to explore rare functional variants. However, most current statistical techniques are too underpowered to capture signals of rare variants in genome-wide association studies. We propose a supervised coalescing of single-nucleotide polymorphisms to obtain gene-based markers that can stably reveal possible genetic effects related to rare alleles. We use a newly developed empirical Bayes variable selection algorithm to identify associations between studied traits and genetic markers. Using our novel method, we analyzed the three continuous phenotypes in the GAW17 data set across 200 replicates, with intriguing results.

RESUMEN

Currently, genome-wide association studies (GWAS) are conducted by collecting a massive number of SNPs (i.e., large p) for a relatively small number of individuals (i.e., small n) and associations are made between clinical phenotypes and genetic variation one single-nucleotide polymorphism (SNP) at a time. Univariate association approaches like this ignore the linkage disequilibrium between SNPs in regions of low recombination. This results in a low reliability of candidate gene identification. Here we propose to improve the case-control GWAS approach by implementing linear discriminant analysis (LDA) through a penalized orthogonal-components regression (POCRE), a newly developed variable selection method for large p small n data. The proposed POCRE-LDA method was applied to the Genetic Analysis Workshop 16 case-control data for rheumatoid arthritis (RA). In addition to the two regions on chromosomes 6 and 9 previously associated with RA by GWAS, we identified SNPs on chromosomes 10 and 18 as potential candidates for further investigation.

RESUMEN

Genome-wide associations between single-nucleotide polymorphisms and clinical traits were simultaneously conducted using penalized orthogonal-components regression. This method was developed to identify the genetic variants controlling phenotypes from a massive number of candidate variants. By investigating the association between all single-nucleotide polymorphisms to the phenotype of antibodies against cyclic citrullinated peptide using the rheumatoid arthritis data provided by Genetic Analysis Workshop 16, we identified genetic regions which may contribute to the pathogenesis of rheumatoid arthritis. Bioinformatic analysis of these genomic regions showed most of them harbor protein-coding gene(s).

RESUMEN

Aberrant glycosylation has been implicated in various types of cancers and changes in glycosylation may be associated with signaling pathways during malignant transformation. Glycomic profiling of blood serum, in which cancer cell proteins or their fragments with altered glycosylation patterns are shed, could reveal the altered glycosylation. We performed glycomic profiling of serum from patients with no known disease (N = 18), patients with high grade dysplasia (HGD, N = 11) and Barrett's esophagus (N = 5), and patients with esophageal adenocarcinoma (EAC, N = 50) in an attempt to delineate distinct differences in glycosylation between these groups. The relative intensities of 98 features were significantly different among the disease onsets; 26 of these correspond to known glycan structures. The changes in the relative intensities of three of the known glycan structures predicted esophageal adenocarcinoma with 94% sensitivity and better than 60% specificity as determined by receiver operating characteristic (ROC) analysis. We have demonstrated that comparative glycomic profiling of EAC reveals a subset of glycans that can be selected as candidate biomarkers. These markers can differentiate disease-free from HGD, disease-free from EAC, and HGD from EAC. The clinical utility of these glycan biomarkers requires further validation.

Asunto(s)